Simplex Trading, LLC Scholar Rock Holding Corp Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$7.84 - $16.79 $223,149 - $477,893	-28,463 Reduced 99.82%	50 $0
Q1 2024 Apr 25, 2024	BUY	$13.2 - $17.76 $348,229 - $468,526	26,381 Added 1237.38%	28,513 $506,000
Q4 2023 Feb 02, 2024	BUY	$6.52 - $20.32 $13,900 - $43,322	2,132 New	2,132 $40,000
Q2 2023 Aug 04, 2023	BUY	$5.79 - $9.11 $5,917 - $9,310	1,022 Added 140.19%	1,751 $13,000
Q1 2023 Apr 27, 2023	BUY	$7.36 - $12.72 $5,365 - $9,272	729 New	729 $5,000
Q2 2022 Aug 03, 2022	BUY	$4.66 - $13.96 $3,168 - $9,492	680 Added 92.52%	1,415 $7,000
Q1 2022 May 02, 2022	BUY	$11.89 - $24.68 $8,739 - $18,139	735 New	735 $9,000
Q2 2021 Aug 12, 2021	SELL	$26.34 - $46.62 $31,608 - $55,944	-1,200 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$45.96 - $68.02 $55,152 - $81,624	1,200 New	1,200 $60,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.